» Articles » PMID: 21681776

Acute Bacterial Inflammation of the Mouse Prostate

Overview
Journal Prostate
Date 2011 Jun 18
PMID 21681776
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prostatic inflammation is gaining increasing attention as a potential etiologic factor in prostate cancer, benign prostatic hyperplasia, lower urinary tract symptoms, and CPPS. This study was performed to address the need for a well characterized model of acute prostatic inflammation that may be used to study the effect of acute inflammation on epithelial and stromal cell proliferation, voiding behavior, and neurovascular physiology.

Methods: Uropathogenic E. coli 1677 was instilled transurethrally into adult C57BL/6J male mice. Prostates were analyzed at 1, 2, 3, 5, 7, or 14 days post-instillation and compared to saline-instilled and naïve controls. Time course and severity of inflammation were characterized by the quantity and type of inflammatory infiltrate present, hemorrhage, proliferation, and reactive hyperplasia. RT-PCR was performed to characterize inflammatory mediators including IL-1α, IL-1β, IL-1RA, IL-18, IL-6, IL-10, IL-8, TNFα, and COX-2.

Results: Inflammation was evident in all lobes of the prostate with the DLP most severely affected. Infection consistently led to a significant increase in neutrophils and macrophages in the early stages of prostate infection, followed by lymphocytic inflammation at the later time points. Inflammation was accompanied by induction of several inflammatory genes, including IL-1 family members, IL-6, and COX-2, and induced a significant increase in epithelial proliferation and reactive hyperplasia in all three prostate lobes.

Conclusions: Transurethral inoculation of uropathogenic E. coli 1677 reliably infects the mouse prostate, produces a significant inflammatory response, and induces quantifiable epithelial proliferation and reactive hyperplasia.

Citing Articles

JAK/STAT signaling maintains an intermediate cell population during prostate basal cell fate determination.

Guo W, Zhang X, Li L, Shao P, Liang C, Zhang H Nat Genet. 2024; 56(12):2776-2789.

PMID: 39537874 DOI: 10.1038/s41588-024-01979-1.


Prevalence and antibiotic susceptibility patterns of uropathogens in men with prostate cancer and benign prostate hyperplasia from Southwestern Nigeria.

Akinpelu S, Olasehinde G, Ikuerowo S, Akinnola O BMC Microbiol. 2024; 24(1):361.

PMID: 39306658 PMC: 11416007. DOI: 10.1186/s12866-024-03524-w.


Exploring the potential mechanism of Xiaojin Pill therapy for benign prostatic hyperplasia through metabolomics and gut microbiota analysis.

Yang Y, Quan Y, Liu Y, Yang J, Chen K, You X Front Microbiol. 2024; 15:1431954.

PMID: 39234552 PMC: 11371748. DOI: 10.3389/fmicb.2024.1431954.


Trichomonas vaginalis adherence phenotypes and extracellular vesicles impact parasite survival in a novel in vivo model of pathogenesis.

Molgora B, Mukherjee S, Baumel-Alterzon S, Santiago F, Muratore K, Sisk Jr A PLoS Negl Trop Dis. 2023; 17(10):e0011693.

PMID: 37871037 PMC: 10621976. DOI: 10.1371/journal.pntd.0011693.


Expression and clinical value of NLRP1 and NLRC4 inflammasomes in prostate cancer.

Liang K, Ke Z, Huang J, Zhang X Oncol Lett. 2023; 26(3):385.

PMID: 37559581 PMC: 10407840. DOI: 10.3892/ol.2023.13971.


References
1.
Sfanos K, Sauvageot J, Fedor H, Dick J, De Marzo A, Isaacs W . A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate. 2008; 68(3):306-20. DOI: 10.1002/pros.20680. View

2.
Jerde T, Bushman W . IL-1 induces IGF-dependent epithelial proliferation in prostate development and reactive hyperplasia. Sci Signal. 2009; 2(86):ra49. PMC: 2949294. DOI: 10.1126/scisignal.2000338. View

3.
Jerde T, Mellon W, Bjorling D, Checura C, Owusu-Ofori K, Parrish J . Stretch induction of cyclooxygenase-2 expression in human urothelial cells is calcium- and protein kinase C zeta-dependent. Mol Pharmacol. 2007; 73(1):18-26. DOI: 10.1124/mol.108.035519. View

4.
Delongchamps N, de la Roza G, Chandan V, Jones R, Sunheimer R, Threatte G . Evaluation of prostatitis in autopsied prostates--is chronic inflammation more associated with benign prostatic hyperplasia or cancer?. J Urol. 2008; 179(5):1736-40. PMC: 2661538. DOI: 10.1016/j.juro.2008.01.034. View

5.
Schauer I, Ressler S, Rowley D . Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model. Prostate. 2008; 69(4):373-84. PMC: 2719820. DOI: 10.1002/pros.20886. View